Pathological and radiological features of false-positive lesions on [68Ga]Ga-PSMA-11 PET/CT in primary staging of prostate cancer: a radio-pathology matching analysis

被引:0
|
作者
Li, Renjie [1 ,2 ]
Fu, Yao [3 ]
Peng, Shan [3 ]
Yang, Fengjiao [4 ]
Ai, Shuyue [4 ]
Wang, Feng [4 ]
Zhang, Shun [1 ,2 ]
Guo, Hongqian [1 ,2 ]
Qiu, Xuefeng [1 ,2 ]
机构
[1] Nanjing Univ, Med Sch, Nanjing Drum Tower Hosp, Dept Urol,Affiliated Hosp, Nanjing 210008, Peoples R China
[2] Nanjing Univ, Inst Urol, Nanjing 210008, Peoples R China
[3] Nanjing Univ, Nanjing Drum Tower Hosp, Affiliated Hosp, Dept Pathol,Med Sch, Nanjing 210008, Peoples R China
[4] Nanjing Med Univ, Nanjing Hosp 1, Dept Nucl Med, Nanjing 210029, Peoples R China
基金
中国国家自然科学基金;
关键词
Ga-68]Ga-PSMA-11 PET/CT; Pathological feature; False-positive; True-negative; True-positive; MULTIPARAMETRIC MRI; EMISSION-TOMOGRAPHY; GA-68-PSMA PET/CT; PI-RADS; DIAGNOSIS; ACCURACY;
D O I
10.1007/s00259-025-07148-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose The aim of this study was to investigate the radiological and pathological characteristics of false-positive lesions on [Ga-68]Ga-PSMA-11 PET/CT during the primary staging of prostate cancer. Methods This study retrospectively analyzed 216 prostate cancer patients who had [Ga-68]Ga-PSMA-11 PET/CT before radical prostatectomy. False-positive lesion was defined as suspicious lesion with PRIMARY score >= 3 on PET/CT but benign on whole-mount pathology. To analyze the radiological and pathological features of false-positive lesions, no-uptake areas on PSMA PET/CT with benign pathology on the whole-mount specimen were randomly delineated and defined as true-negative lesions. The pathological features of false-positive and true-negative lesions were compared using Fisher's exact test. The differences of SUVmax and SUVmean between false-positive and true-positive lesions were determined and compared using the Wilcoxon matched-pairs signed-ranks test. In addition, PSMA expression in false-positive lesions was assessed by immunohistochemistry. Results A total of 36 false-positive lesions were identified on [Ga-68]Ga-PSMA-11 PET/CT: 25 (69.44%) were simple atrophy with cyst formation, 7 (19.44%) were prostatic nodular hyperplasia, 3 (8.33%) were inflammation and 1 (2.78%) was normal glands. A comparable number of 36 true-negative lesions were delineated: 21 (58.33%) were normal glands, 8 (22.22%) were simple atrophy with cyst formation, 6 (16.67%) were prostatic nodular hyperplasia, and 1 (2.78%) were inflammation. The Fisher's exact test revealed a statistically significant difference in the prevalence of simple atrophy with cyst formation between false-positive and true-negative lesions (69.44% vs. 22.22%; P < 0.001). Differences in SUVmax and SUVmean between false-positive and true-positive lesions were also statistically significant (both P < 0.001). PSMA expression in false-positive lesions was confirmed via immunohistochemistry. Conclusion This study determined that simple atrophy with cyst formation is a distinctive pathological feature of false-positive lesions on [Ga-68]Ga-PSMA-11 PET/CT. This observation is likely attributable to the elevated PSMA expression in simple atrophy with cyst formation, as confirmed by histological analysis. Additionally, false-positive lesions were found to have significantly lower SUV compared to true-positive lesions.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] The impact of (68Ga)-Ga-PSMA-11 PET/CT in primary staging of prostate cancer
    Weitzer, F.
    Pernthaler, B.
    Plhak, E.
    Riedl, R.
    Aigner, R. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S458 - S458
  • [2] Pathological features of prostatic false-positive lesions on 68Ga-PSMA-11 PET/CT
    Li, R.
    Fu, Y.
    EUROPEAN UROLOGY, 2024, 85 : S1090 - S1090
  • [3] Cost-effectiveness of the implementation of [68Ga]Ga-PSMA-11 PET/CT at initial prostate cancer staging
    Esmée C. A. van der Sar
    Willem R. Keusters
    Ludwike W. M. van Kalmthout
    Arthur J. A. T. Braat
    Bart de Keizer
    Geert W. J. Frederix
    Anko Kooistra
    Jules Lavalaye
    Marnix G. E. H. Lam
    Harm H. E. van Melick
    Insights into Imaging, 13
  • [4] Cost-effectiveness of the implementation of [68Ga]Ga-PSMA-11 PET/CT at initial prostate cancer staging
    van der Sar, Esmee C. A.
    Keusters, Willem R.
    van Kalmthout, Ludwike W. M.
    Braat, Arthur J. A. T.
    de Keizer, Bart
    Frederix, Geert W. J.
    Kooistra, Anko
    Lavalaye, Jules
    Lam, Marnix G. E. H.
    van Melick, Harm H. E.
    INSIGHTS INTO IMAGING, 2022, 13 (01)
  • [5] Primary Staging of Prostate Cancer Patients with [18F]PSMA-1007 PET/CT Compared with [68Ga]Ga-PSMA-11 PET/CT
    Hoffmann, Manuela A.
    Mueller-Huebenthal, Jonas
    Rosar, Florian
    Fischer, Nicolas
    von Eyben, Finn Edler
    Buchholz, Hans-Georg
    Wieler, Helmut J.
    Schreckenberger, Mathias
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (17)
  • [6] Assessing dynamic metabolic heterogeneity in prostate cancer patients via total-body [68Ga]Ga-PSMA-11 PET/CT imaging: quantitative analysis of [68Ga]Ga-PSMA-11 uptake in pathological lesions and normal organs
    Ruohua Chen
    Yee Ling Ng
    Xinlan Yang
    Yinjie Zhu
    Lianghua Li
    Haitao Zhao
    Gang Huang
    Jianjun Liu
    European Journal of Nuclear Medicine and Molecular Imaging, 2024, 51 : 896 - 906
  • [7] Assessing dynamic metabolic heterogeneity in prostate cancer patients via total-body [68Ga]Ga-PSMA-11 PET/CT imaging: quantitative analysis of [68Ga]Ga-PSMA-11 uptake in pathological lesions and normal organs
    Chen, Ruohua
    Ng, Yee Ling
    Yang, Xinlan
    Zhu, Yinjie
    Li, Lianghua
    Zhao, Haitao
    Huang, Gang
    Liu, Jianjun
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (03) : 896 - 906
  • [8] Diagnostic value of two-time point [68Ga]Ga-PSMA-11 PET/CT in the primary staging of untreated prostate cancer
    Friedrich Weitzer
    Birgit Pernthaler
    Elisabeth Plhak
    Regina Riedl
    Reingard Maria Aigner
    Scientific Reports, 13
  • [9] Diagnostic value of two-time point [68Ga]Ga-PSMA-11 PET/CT in the primary staging of untreated prostate cancer
    Weitzer, Friedrich
    Pernthaler, Birgit
    Plhak, Elisabeth
    Riedl, Regina
    Aigner, Reingard Maria
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [10] [68Ga]Ga-PSMA-11 PET/CT in Thyroid Cancer Preliminary Results
    Zajkowska, K.
    Wojewodzka-Mirocha, M.
    Cegla, P.
    Sackiewicz, A.
    Ochman, P.
    Januszkiewicz-Caulier, J.
    Zylka, A.
    Dedecjus, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S549 - S550